CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >

2020 , Vol. 38 >Issue 1: 1 - 4

DOI: https://doi.org/10.12140/j.issn.1000-7423.2020.01.001

EXPERT VIEWPOINT

Suggestions for standardizing the process of malaria diagnosis and treatment during the epidemic control of coronavirus disease(COVID-19)

  • ZOU Yang ,
  • ZHENG Yi-shan ,
  • CAO Jun
Expand
  • 1 Emergency and Critical Care Center, Beijing Friendship Hospital, Capital Medical University, Beijing Institute of Tropical Medicine, Beijing Key Laboratory for Research on Prevention and Treatment of Tropical Diseases, Beijing 100050, China;
    2 The Second Hospital of Nanjing, Jiangsu Provincial Infectious Disease Hospital, Nanjing 210003, China;
    3 Jiangsu Institute of Parasitic Diseases, WHO Collaborating Center for Research and Training on Malaria Elimination, Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Wuxi 214064, China

Received date: 2020-02-21

  Online published: 2020-03-19

Supported by

Supported by the Jiangsu Provincial Department of Science and Technology (No. BM2018020), and the Jiangsu Provincial Project of Invigorating Health Care through Science, Technology and Education

Fold

Abstract

At the end of 2019, the epidemic of coronavirus disease 2019 (COVID-19) brought new challenges to the diagnosis and treatment of other diseases such as malaria. If malaria patients are misdiagnosed, the illness may become severe or even life-threatening. Furthermore, if improperly protected and handled against the epidemic, not only malaria patients may be infected with the novel coronavirus during the process seeking for medical care, but medical staff will also face potential high risks. Therefore, to provide reference for health care workers, this paper focuses on how to perform good practice for malaria diagnosis and treatment under the current COVID-19 epidemic, and provides recommendations for the standardized diagnosis and treatment process of malaria patients.

Key words： Coronavirus disease 2019; Malaria; Diagnosis and treatment

Cite this article

ZOU Yang , ZHENG Yi-shan , CAO Jun . Suggestions for standardizing the process of malaria diagnosis and treatment during the epidemic control of coronavirus disease(COVID-19)[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020 , 38(1) : 1 -4 . DOI: 10.12140/j.issn.1000-7423.2020.01.001

References

[1] The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China[J]. Chin J Epidemiol, 2020, 41(2): 145-151. (in Chinese)
(中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151)
[2] World Health Organization. Novel coronavirus-China. Geneva: World Health Organization [EB/OL]. (2020-01-12) [2020-02-20]. https://www.who.int/csr/don/12-january-2020-novel-co ronavi rus-china/en/.
[3] Li Q, Guan XH, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020. doi: 10.1056/NEJMoa2001316.
[4] World Health Organization. World malaria report 2019[R]. Geneva: WHO, 2019.
[5] Zhang L, Feng J, Zhang SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018[J]. Chin J Parasitol Parasit Dis, 2019, 37(3): 241-247. (in Chinese)
(张丽, 丰俊, 张少森, 等. 2018年全国疟疾疫情特征及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3): 241-247.)
[6] National Health Commission of the People’s Republic of China. Notice on strengthening the management of fever clinics in key hospital of key area and prevention and control of nosocomial infection in medical institutions[EB/OL]. (2020-02-04)[2020-02-20]. http://www.nhc.gov.cn/yzygj/s7659/202002/485aac6af5d54788a05b3bcea5a22e34.shtml. (in Chinese)
(中华人民共和国国家卫生健康委. 关于加强重点地区重点医院发热门诊管理及医疗机构内感染防控工作的通知[EB/OL]. (2020-02-04)[2020-02-20]. http://www.nhc.gov.cn/yzygj/s7659/202002/485aac6af5d54788a05b3bcea5a22e34.shtml
[7] Diagnosis of malaria (WS 259-2015)[S]. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2016. (in Chinese)
(疟疾的诊断(WS 259-2015)[S]. 北京: 中华人民共和国卫生和计划生育委员会, 2016.)
[8] Chinese society of laboratory medicine. Biosafety consensus for 2019 novel coronavirus pneumonia in clinical laboratory[J]. Chin J Lab Med, 2020, 43. DOI:10.3760/cma.j.issn.1009-8158.2020.0001. (in Chinese)
(中华医学会检验医学分会. 2019新型冠状病毒肺炎临床实验室生物安全防护专家共识[J]. 中华检验医学杂志, 2020, 43. DOI:10.3760/cma.j.issn.1009-8158.2020.0001)
[9] National Health Commission of the People’s Republic of China. The technical guidelines for novel coronavirus pneumonia diagnosis and treatment (version 6)[EB/OL]. (2020-02-19)[2020-02-20]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. (in Chinese)
(中华人民共和国国家卫生健康委. 新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL]. (2020-02-19)[2020-02-20]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml
[10] The technical regulations for application of antimalarials(WS/T 485-2016)[S]. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2016. (in Chinese)
(抗疟药使用规范(WS/T 485-2016)[S]. 北京: 中华人民共和国卫生和计划生育委员会, 2016.)
[11] National Health Commission of the People’s Republic of China. Notice on adjusting the dosage and use of chlorofluorophosphate in the treatment of COVID-19 [EB/OL]. (2020-02-28)[2020-02-28]. http://www.nhc.gov.cn/yzygj/s7653p/202002/0293d017621941f6b 2a4890035243730.shtml. (in Chinese)
(中华人民共和国国家卫生健康委. 关于调整试用磷酸氯喹治疗新冠肺炎用法用量的通知[EB/OL]. (2020-02-28)[2020-02-28]. http://www.nhc.gov.cn/yzygj/s7653p/202002/0293d01762194 1f6b2a4890035243730.shtml
Options
Outlines

/

〈 〉